DABIGATRAN 75 MG TAB,DANAZOL 100 MG TAB,DARIFENACIN 15 MG TAB,DEXAMETHASONE 4MG TAB,ED NETARSUDIL 0
Indian Army
CENTRAL DELHI, DELHI
Bid Publish Date
13-Jan-2025, 3:53 pm
Bid End Date
24-Feb-2025, 4:00 pm
Location
Progress
Quantity
52660
Bid Type
Two Packet Bid
Indian Army invites bids for Methotrexate 5mg tab, Naproxen 250mg tab, Neomycin plus Polymixin plus Bacitdracin neosporin oint, Ravistigmine 1. 5mg cap, Nitrofurantoin 100mg cap in CENTRAL DELHI, DELHI. Quantity: 52660. Submission Deadline: 24-02-2025 16: 00: 00. Submit your proposal before the deadline.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Methotrexate 5mg tab , Naproxen 250mg tab , Neomycin plus Polymixin plus Bacitdracin neosporin oint , Ravistigmine 1.5mg cap , Nitrofurantoin 100mg cap
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
OTHER
Indian Army
CENTRAL DELHI, DELHI
Indian Army
AMRITSAR, PUNJAB
Indian Army
PATIALA, PUNJAB
Indian Army
AMRITSAR, PUNJAB
Indian Army
PATIALA, PUNJAB
Tender Results
Loading results...
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | B LAL & SONS Under PMA | - | 25-01-2025 18:47:21 | |
| 2 | GARG MEDICAL STORE Under PMA | - | 21-02-2025 16:42:15 | |
| 3 | GOYAL MEDICAL & GENERAL AGENCY Under PMA | - | 24-02-2025 14:53:44 | |
| 4 | HEALER'S LAB Under PMA | - | 24-02-2025 11:02:26 | |
| 5 | LUNAAS PHARMACEUTICALS Under PMA | - | 22-02-2025 10:13:16 | |
| 6 | M/S NEW WAVES Under PMA | - | 24-02-2025 14:02:34 | |
| 7 | M/S RAJEEV MEDICAL STORE Under PMA | - | 24-02-2025 02:17:49 | |
| 8 | NEW LIFE MEDICOS Under PMA | - | 21-02-2025 12:01:56 | |
| 9 | PRATHMESH DISTRIBUTOR Under PMA | - | 15-02-2025 17:39:33 | |
| 10 | R.P.S.PHARMA Under PMA | - | 24-02-2025 14:19:05 | |
| 11 | SARV REMEDI HEALTHCARE Under PMA | - | 22-02-2025 17:34:20 | |
| 12 | SHRI RAM MEDICAL Under PMA | - | 22-02-2025 12:56:44 | |
| 13 | SHRISHTI PHARMACEUTICAL & SURGICALS Under PMA | - | 22-02-2025 18:59:17 | |
| 14 | SMPL LIFE SCIENCES PRIVATE LIMITED Under PMA | - | 22-02-2025 17:44:00 | |
| 15 | SRI G PHARMACEUTICALS Under PMA | - | 22-02-2025 15:18:23 | |
| 16 | SRI SAI AGENCIES Under PMA | - | 19-02-2025 22:28:32 | |
| 17 | SUKUN PHARMA Under PMA | - | 11-02-2025 16:53:37 | |
| 18 | SUNIL PHARMACY Under PMA | - | 24-02-2025 11:47:30 | |
| 19 | UJJAWAL OVERSEAS (INDIA) PRIVATE LIMITED Under PMA | - | 22-02-2025 13:50:30 | |
| 20 | VANDANA MEDICO TRADERS Under PMA | - | 22-02-2025 17:54:56 |
Key insights about DELHI tender market
The eligibility requirements include being a registered legal entity in India, proving past performance in similar supply contracts, meeting specified financial turnover thresholds, and submitting relevant experience documentation as mentioned in the tender overview.
Bidders must include certificates such as OEM Authorization Certificates, compliance certifications regarding the quality standards of medications, and any additional profit and turnover documentation as specified in the tender guidelines.
To participate in this procurement, bidders must register on the official tendering platform, ensuring they have the necessary documents mentioned in the eligibility criteria and submit their proposals electronically.
Accepted document formats typically include standard PDF or specific file types as stated in the submission guidelines. It is crucial to follow the instructions outlined in the tender documentation.
The technical specifications require compliance with dosages, quality assurance standards, and adherence to the BoQ provided by the Ministry of Defence. Bidders must provide detailed documentation to demonstrate compliance.
Bidders must conform to national and international quality standards set for pharmaceuticals. Documentation proving adherence to these standards must also be submitted alongside technical proposals.
Compliance requirements include the provision of specified certificates, documentation proving past performance, and financial turnover. Additionally, bidders must adhere to ethical and regulatory frameworks outlined in the tender document.
The evaluation will consider testing criteria based on adherence to the quality specifications outlined in the tender, past performance in supply contracts, and financial soundness as per the guidelines.
The Earnest Money Deposit (EMD) amount is specified in the tender documentation and must be submitted at the time of bid submission to demonstrate commitment and serious intent to fulfill the contract if awarded.
Successful bidders must submit a performance security, generally as a percentage of the contract value, to ensure compliance with contract terms and obligations during the contract execution phase.
Payment terms will generally be detailed in the tender document and may include milestones tied to delivery schedules, providing clarity on payment timelines and conditions for different stages of the procurement process.
Price evaluations will consider the comprehensive cost per unit submitted by bidders, taking into account evaluated quality and compliance with technical specifications. Optimal pricing alongside qualitative proposals will be a significant factor in final selections.
Bidders must submit their documentation through the specified electronic submission platforms as detailed in the tender. Manual submissions are typically not accepted unless otherwise stated in special provisions.
Detailed timelines and deadlines for submissions, evaluations, and other phases can be found in official documents associated with this tender. Bidders should ensure compliance with all specified timelines to avoid disqualification.
The selection process comprises an item-wise evaluation of both technical and financial bids, ensuring a fair appraisal based on multiple factors including compliance, quality, and pricing to select the most capable supplier.
Results will typically be communicated to bidders shortly after the evaluation process. This information will be made available through official channels as stated within the tender documents provided to the bidders.
MSEs may receive preferential treatment, including exemptions from certain eligibility criteria, financial support, and other benefits aimed at encouraging small businesses to participate in government tenders.
Startups may benefit from certain relaxations in eligibility criteria. Specific provisions encouraging startup participation can be referenced in the terms outlined in the tender documentation.
This procurement supports the 'Make in India' initiative by promoting local manufacturing and sourcing, thereby strengthening domestic capabilities in pharmaceuticals and related sectors as mandated by government policies.
Local content and procurement rules necessitate that a certain percentage of the materials and products be sourced from domestic suppliers, thereby promoting local manufacturing and sustainability in government procurements.
Indian Air Force
📍 BANGALORE, KARNATAKA
Indian Army
📍 LUCKNOW, UTTAR PRADESH
Indian Air Force
📍 BANGALORE, KARNATAKA
Dg Of Defence Estate
📍 ALMORA, UTTARAKHAND
Indian Army
📍 JABALPUR, MADHYA PRADESH
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
OTHER